News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lectus Therapeutics Ltd. Secures £3Million Investment from the Wellcome Trust



9/5/2007 11:45:22 AM

Cambridge, UK 05 September 2007, Lectus Therapeutics Ltd, the drug discovery and development company focusing on next-generation ion channel modulators, announced today that the Wellcome Trust provided £3million of investment capital to fund a specific programme to identify new classes of selective potassium channel modulator drug candidates for the treatment of multiple sclerosis.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES